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Abstract
The extracellular matrix (ECM) receptor dystroglycan (DG) serves as a cellular receptor for the
highly pathogenic arenavirus Lassa virus (LASV) that causes a hemorrhagic fever with high
mortality in man. In the host cell, DG provides a molecular link between the ECM and the actin
cytoskeleton via the adapter proteins utrophin or dystrophin. Here we investigated post-
translational modifications of DG in the context of LASV cell entry. Using the tyrosine kinase
inhibitor genistein, we found that tyrosine kinases are required for efficient internalization of virus
particles, but not virus-receptor binding. Engagement of cellular DG by LASV envelope
glycoprotein (LASV GP) in human epithelial cells induced tyrosine phosphorylation of the
cytoplasmic domain of DG. LASV GP binding to DG further resulted in dissociation of the
adapter protein utrophin from virus-bound DG. This virus-induced dissociation of utrophin was
affected by genistein treatment, suggesting a role of receptor tyrosine phosphorylation in the
process.
INTRODUCTION
The Old World arenavirus Lassa virus (LASV) is the causative agent of a severe viral
hemorrhagic fever in humans with several hundred thousand infections per year in Africa
and thousands of deaths annually (McCormick and Fisher-Hoch, 2002). Fatal LASV
infection is characterized by rapid viral replication and spread, resulting in uncontrolled viral
infection with progressive signs and symptoms of hemorrhagic disease and shock (Geisbert
and Jahrling, 2004). The death toll of LASV infection among hospitalized patients can reach
15-30%. There is no licensed vaccine against LASV and current therapeutic options are
limited, making LASV arguably one of the most neglected tropical pathogens.
Arenaviruses are enveloped negative-strand RNA viruses with a bi-segmented genome,
whose replication takes place in the cytoplasm (de la Torre, 2009; Buchmeier et al., 2007).
The two viral RNA segments, L and S, include each two open reading frames. The S
segment encodes the envelope glycoprotein precursor (GPC) and the nucleoprotein (NP) and
the L segment codes for the matrix protein (Z) and the viral polymerase (L). LASV GPC is
synthesized as a single polypeptide and undergoes processing by the host cell protease
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subtilisin kexin isozyme-1(SKI-1)/site-1 protease (S1P) (Rojek et al., 2008b; Beyer et al.,
2003; Lenz et al., 2001), yielding the N-terminal GP1 and the transmembrane GP2. LASV
GP1 is involved in binding to cellular receptors (Borrow and Oldstone, 1992), whereas the
GP2 part mediates fusion and resembles the membrane-proximal regions of other viral
fusion proteins (Igonet et al., 2011; Eschli et al., 2006).
Binding of a virus to its cellular receptor(s) and subsequent entry into target cells are the
first steps of virus infection and a fundamental aspect of the virus-host cell interaction.
These initial steps of infection are also promising targets to block the pathogen before it can
take control over the host cell. Therapeutic intervention at the level of cell entry is of
particular interest for highly pathogenic viruses like LASV. The first cellular receptor
discovered for LASV and the prototypic Old World arenavirus lymphocytic
choriomeningitis virus (LCMV) is dystroglycan (DG) a ubiquitous receptor for extracellular
matrix (ECM) proteins (Oldstone and Campbell, 2011; Cao et al., 1998). More recently,
additional candidate receptors for LASV have been reported, including the C-type lectins
DC-SIGN, LSECtin, and the Tyro3/Axl/Mer (TAM) receptor tyrosine kinases Axl and
Tyro3 (Shimojima et al., 2012). However, in DG-expressing cells, DG appears to be the
preferred receptor for LASV (Shimojima et al., 2012).
Dystroglycan is a highly conserved protein initially translated as a single polypeptide chain
that is cleaved into the extracellular α-DG, and transmembrane β-DG (Barresi and
Campbell, 2006). DG is expressed in most developing and adult tissues in cells that adjoin
basement membranes (Durbeej et al., 1998) and is crucial for normal cell-matrix interactions
(Henry et al., 2001; Henry and Campbell, 1998). Alpha-DG has a central, highly
glycosylated mucin-type domain that connects the globular N-and C-terminal domains. At
the extracellular site, α-DG undergoes high-affinity interactions with the ECM proteins
laminin, agrin, perlecan, and neurexins (Barresi and Campbell, 2006). Alpha-DG is non-
covalently associated with β-DG, which binds intracellular to the adaptor proteins
dystrophin or utrophin that link DG to the actin cytoskeleton. DG is also associated with a
number of signaling molecules, including the adaptor molecule grb2 (Yang et al., 1995), the
canonical MAP kinases MEK and ERK (Spence et al., 2004), and the focal adhesion kinase
(Cavaldesi et al., 1999). Upon receptor binding, LASV and LCMV are internalized via an
endocytotic pathway that is independent of clathrin, caveolin, and dynamin and bypasses
classical Rab5-dependent incoming routes of vesicular trafficking (Quirin et al., 2008; Rojek
et al., 2008c). During cell entry, LASV and LCMV pass through the multivesicular
endosome, where the virus-receptor complex undergoes sorting by the endosomal sorting
complex required for transport (ESCRT) delivering the viruses to late endosomes, where
low pH-induced fusion occurs after 20-30 minutes (Pasqual et al., 2011; Quirin et al., 2008;
Rojek et al., 2008c).
In the host cell, DG appears as a structural component of cell-matrix contacts, which suggest
a rather static role. Considering the receptor dynamics expected in the context of LASV cell
entry, we hypothesized that virus binding may alter DG trafficking, e.g. by inducing post-
translational modifications that target the DG complex towards rapid endocytosis. Studies in
prototypic primate and human cells had demonstrated that cell adhesion to ECM proteins
can induce phosphorylation of tyrosine Y892 located within a PPxY motif present at the C-
terminus of the cytoplasmic domain of β-DG by non-receptor tyrosine kinases of the src
family (Sotgia et al., 2003; Sotgia et al., 2001; James et al., 2000). This tyrosine
phosphorylation of Y892 prevented the association of β-DG with the cytoskeletal adaptor
protein utrophin (James et al., 2000) and resulted in a redistribution of the DG complex from
the plasma membrane to intracellular compartments (Sotgia et al., 2003), linking tyrosine
phosphorylation of β-DG to receptor internalization. More recent studies confirmed a role of
tyrosine phosphorylation of β-DG at Y892 for the endocytosis of DG in myoblasts and
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provide evidence for a role of tyrosine phosphorylation of DG in the development of muscle
pathophysiology in an animal model for muscular dystrophy (Miller et al., 2012). In the
present study we investigated the role of receptor tyrosine phosphorylation for cell entry of
LASV.
RESULTS
Tyrosine kinases are involved in endocytosis of rLCMV-LASVGP
Recent studies using the broadly specific tyrosine kinase inhibitor genistein revealed a role
for tyrosine kinases in cell entry of LASV (Kolokoltsov et al., 2012). However, the specific
step(s) of the viral entry process that depend on tyrosine kinases had not yet been defined. In
a first step, we sought to confirm and extend these earlier studies and tried to distinguish
effects of genistein on virus-cell attachment from endocytosis. Since LASV is a BSL4
pathogen, work with live virus is restricted to laboratories with high security containment.
To circumvent these biosafety restrictions, we used a recombinant form of the prototypic
LCMV expressing the envelope GP of LASV (rLCMV-LASVGP) (Rojek et al., 2008c). The
chimera rLCMV-LASVGP does not show significant attenuation in vitro when compared to
the parental LCMV strain and grows to robust titers. Since receptor binding and host cell
entry of arenaviruses are mediated exclusively by the viral GP, rLCMV-LASVGP adopts the
receptor binding characteristics of LASV (Rojek et al., 2008c) and represents a suitable
BSL2 surrogate for our studies on LASV-receptor interaction and cell entry. As a cell
culture model, we chose the human lung epithelial cell line WI-26 VA4, which had
previously been utilized for studies on DG signaling (Ferletta et al., 2003) and the
interaction of LASV with its receptor DG (Rojek et al., 2012).
First, we verified that cell attachment and entry of LASV into WI-26 VA4 cells was
mediated by DG. Cells were pre-treated with increasing concentration of the monoclonal
antibody (mAb) IIH6 that recognizes a functional glycan epitope on α-DG (Kanagawa et al.,
2004) and competes with virus binding (Kunz et al., 2005b). Cells were then infected with
rLCMV-LASVGP and infected cells detected after 16 hours by immunofluorescence (IF)
staining of the viral nucleoprotein (NP). Pre-treatment with mAb IIH6, but not an IgM
isotype control significantly blocked infection with rLCMV-LASVGP in a dose-dependent
manner, confirming DG as a major receptor for LASV in these cells (Fig. 1A), as shown
previously (Rojek et al., 2012).
To exclude unspecific cytotoxicity caused by genistein, WI-26 VA4 cells were treated with
increasing concentrations of the drug for 4 hours, followed by a wash out and incubation for
a total of 16 hours. Cell viability was assessed by Cell Titer Glo® assay, which measures
intracellular levels of ATP. WI-26 VA4 cells tolerated genistein up to a concentration of 100
μM with only mild loss of cell viability (Fig. 1B). To test the effect of genistein on early
infection with LCMV-LASVGP, WI-26 VA4 cells were pre-treated with increasing
concentrations of genistein for one hour and infected with rLCMV-LASVGP at multiplicity
of 1. At four hours post infection, the drug was removed by wash out. To prevent further
infection, the lysosomotropic agent ammonium chloride was added to the fresh medium.
When added to cells ammonium chloride raises the endosomal pH rapidly and blocks low
pH-dependent membrane fusion without causing overall cytotoxicity (Ohkuma and Poole,
1981; Ohkuma and Poole, 1978). After 12 hours in presence of ammonium chloride, cells
were fixed and infection detected by IF staining for LCMV NP. As shown in Fig. 1C,
genistein blocked infection with rLCMV-LASVGP in a dose-dependent manner.
Using expression of LCMV NP in infected cells as readout for infection did not allow
discriminating between effects of genistein on LASVGP-mediated cell entry and post-entry
steps of early viral infection. To specifically validate the effects of genistein on LASV cell
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entry in our system, we used recombinant vesicular stomatitis virus (VSV) pseudotyped with
the envelope GPs of LASV (rVSV-LASVGP) and VSV (rVSV-VSVG). These pseudotypes
are replications deficient and contain a green fluorescent protein (GFP) reporter in their
genome. Previous studies demonstrated that rVSV-LASVGP closely mimic the receptor
binding and entry characteristics of LASV (Pasqual et al., 2011; Kunz et al., 2005a).
Increasing concentrations of genistein blocked infection of rVSV-LASVGP more efficient
than rVSV-VSVG (Fig. 1D), consistent with previous reports (Kolokoltsov et al., 2012).
Notably, the dose-response characteristic of rVSV-LASVGP closely matched the one of
rLCMV-LASVGP (Fig. 1C, D), indicating that at least some of the inhibitory effect of
genistein on early infection with rLCMV-LASVGP was due to perturbation of LASVGP-
mediated cell entry.
To differentiate between effects of genistein on LASVGP-mediated cell attachment from
perturbation of endocytosis, we used a well-established assay previously used to study virus
internalization (Rojek et al., 2008a; Pelkmans et al., 2002), schematically shown in Fig. 1E.
Briefly, rLCMV-LASVGP was purified over a renografin gradient and purified virus labeled
with the reagent NHS-SS-biotin, resulting in a biotin label that is cleavable by reducing
agents. As long as the virus stays bound to the cell surface, the biotin label can be cleaved
efficiently with the potent, membrane-impermeable reducing agent Tris(2-
carboxyethyl)phosphine (TCEP) (Fig. 1E). Once internalized via endocytosis, the biotin-
labeled virus is protected from TCEP and retains its biotin moiety after exposure of cells to
TCEP. To assess possible effects of genistein on virus cell attachment and internalization,
WI-26 VA4 cells were pre-treated with 50 μM of genistein or vehicle control. After one
hour, cells were cooled on ice and incubated with biotin-labeled rLCMV-LASVGP (100
particles/cell) for one hour in the cold. Unbound virus was removed and cells shifted to 37
°C in presence of genistein. After the indicated time points, cells were rapidly chilled on ice
and immediately treated with cold TCEP or reaction buffer only. After quenching of residual
TCEP with iodacetamide, cells were lysed and the viral GP isolated by immunoprecipitation
(IP) with mAb 83.6 to GP2. Proteins were separated by SDS-PAGE and biotinylation of
GP2 detected by Western-blot under non-reducing conditions. In specimens treated with
reaction buffer only, similar amounts of cell-associated biotinylated virus were detected in
presence and absence of genistein (Fig. 1F), indicating that genistein treatment did not affect
virus attachment to the receptor. In control samples treated with TCEP, biotinylated virus
became detectable after circa 5 min, with an increase over the next 20 min. In cells treated
with genistein and TCEP, the signals for biotinylated GP2 were markedly reduced,
indicating a block in an early step of virus internalization in presence of the inhibitor. In
sum, our studies revealed that genistein does not affect virus-cell attachment, but inhibits the
subsequent early steps of virus internalization.
Binding of LASV to cellular DG induces tyrosine phosphorylation of β-DG
Since the binding of LASV to DG is of high affinity and virtually irreversible under neutral
pH (Kunz et al., 2005a), we speculated that virus-bound DG may be internalized during
endocytosis of the virus. The apparent block of virus internalization in presence of genistein
at an early time point (5-20 min) (Fig. 1E) opened therefore the possibility that uptake of the
virus-receptor complex could involve tyrosine phosphorylation of the receptor and/or
receptor-associated cellular factors. Since phosphorylation of β-DG at residue Y892 had
previously been linked to internalization of the DG complex (Miller et al., 2012; Sotgia et
al., 2003), we monitored phosphorylation of DG at Y892 during LASV cell entry. For this
purpose, we applied mAb cl14a that specifically recognizes β-DG phosphorylated at Y892
(Sotgia et al., 2003). In a first step, we confirmed the specificity of mAb cl14a in our
system. To this end, we co-expressed recombinant full-length DG containing a C-terminal
HA-tag (DGHA, Fig. 2A) with recombinant c-src in HEK293 cells. Previous studies
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demonstrated that C-terminal tagging of β-DG had no influence on the biosynthesis,
transport, and function of DG (Rojek et al., 2007b). Cells were either treated with the
specific src tyrosine kinase family inhibitor PP2 (20 μM) or mock treated. After 48 hours,
DGHA was isolated by IP with HA matrix and phosphorylation of Y892 detected with mAb
cl14a in Western-blot. As expected, DGHA isolated from cells over-expressing c-src was
specifically recognized by mAb cl14a, whereas treatment with PP2 markedly reduced the
signal, confirming the specificity of the assay (Fig. 2B).
To examine the effect of LASV binding on tyrosine phosphorylation of DG at Y892,
monolayers of WI-26 VA4 cells were incubated with rLCMV-LASVGP (100 particles per
cell). Virus attachment was performed in the cold to allow virus binding but preventing
lateral movement of receptor molecules in the membrane. As a control, we used the New
World arenavirus Pichinde (PICV) that does not bind to α-DG (Spiropoulou et al., 2002).
After removal of unbound virus, cells were rapidly shifted to 37°C to restore membrane
fluidity. At the indicated time points, cells were lysed in presence of the phosphatase
inhibitor sodium orthovanadate. Cleared cell lysates were subjected to lectin purification
with wheat germ agglutinin (WGA). Precipitated proteins were separated by SDS-PAGE
and probed with mAb cl14a anti-β-DGPY892 and mAb 8D5 to β-DG that binds
independently of phosphorylation. Binding of rLCMV-LASVGP, but not PICV resulted in
transient phosphorylation of β-DG at Y892 (Fig. 2C) with maximal signals observed after
5-10 minutes. To confirm the role of src family kinases in the apparent virus-induced
receptor phosphorylation at Y892, we treated cells with the src kinase inhibitor PP2 for 30
minutes prior to addition of virus. As shown in Fig. 2D, pretreatment with PP2 markedly
reduced virus-induced tyrosine phosphorylation of β-DG at Y892, indicating a direct or
indirect involvement of src kinases. In some experiments, we observed an apparent decrease
in total β-DG at later time points (Fig. 2C, D). However, this was not observed consistently.
To address a possible role of the observed virus-induced receptor phosphorylation at Y892
for viral entry, we monitored the entry kinetics of LASV in presence of PP2. Upon receptor
binding, LASV is taken up by clathrin- and caveolin-independent endocytosis and rapidly
delivered to late endosomes, where low pH-dependent membrane fusion occurs (Quirin et
al., 2008; Rojek et al., 2008a; Rojek et al., 2008c; Borrow and Oldstone, 1994). To assess
how fast receptor-bound rLCMV-LASVGP trafficked to late endosomes in presence and
absence of PP2, we determined the time required for the virus to become resistant to
ammonium chloride. Briefly, WI-26 VA4 cells were either pretreated with PP2 for one hour,
or mock treated with vehicle (DMSO) only. Cells were then incubated with
rLCMVLASVGP in the cold, allowing virus attachment without internalization. Unbound
virus was removed and cells quickly shifted to 37 °C to allow virus internalization in
presence or absence of PP2. After different time points, 20 mM ammonium chloride was
added to cells and kept throughout the experiment. At 16 h post infection, cells were fixed
and infection assessed by IF detection NP. As shown in Fig. 2E pretreatment of cells with
PP2 had no significant effect on the entry kinetics of rLCMV-LASVGP, suggesting that
tyrosine phosphorylation of β-DG at Y892 was dispensable for virus cell entry. To
complement these inhibitor studies, we examined the entry kinetics of rLCMV-LASVGP in
murine embryonic fibroblasts (MEFs) derived from mice deficient for the src-family kinases
src, fyn, and yes (Newsome et al., 2006). When compared to wild-type MEFs, src/fyn/yes-
deficient cells were infected with similar kinetics (data not shown), in line with our src
kinase inhibitor studies (Fig. 2E).
Despite the marked inhibition of rLCMV-LASVGP internalization by genistein (Fig. 1F),
treatment of cells with the src inhibitor PP2 did not affect LASV cell entry, which was rather
unexpected. Examination of the sequence of the cytoplasmic tail of β-DG revealed the
presence of four putative sites of tyrosine phosphorylation, in addition to Y892 (Fig. 3A). To
Moraz et al. Page 5
Cell Microbiol. Author manuscript; available in PMC 2013 November 01.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
assess tyrosine phosphorylation of β-DG in response to LASV binding at sites other than
Y892, WI-26 VA4 cells were pretreated with PP2 or vehicle, followed by exposure to
rLCMV-LASVGP as described above. After the indicated time points, β-DG was isolated by
IP using mAb 8D5 that does not discriminate between phosphorylated and unphosphorylated
β-DG. Immunocomplexes were separated by SDS-PAGE and probed in Western blot using
mAb cl14a to β-DGPY892 and mAb 4G10 to tyrosine phosphate. Total β-DG was detected
with polyclonal antibody AP83. As expected, treatment with PP2 prevented virus-induced
phosphorylation at Y892 (Fig. 3B). However, immunoblotting with the broadly specific
anti-phosphotyrosine mAb 4G10 revealed significant tyrosine phosphorylation of β-DG in
response to virus binding that was not affected by PP2 (Fig. 3B). This suggested that binding
of rLCMV-LASVGP to cellular DG induced tyrosine phosphorylation of β-DG at sites other
than Y892, possibly implicating non-src family tyrosine kinases. Pre-treatment of cells with
genistein (50 μM) for 30 minutes reduced virus-induced tyrosine phosphorylation of β-DG
altogether (Fig. 3C).
Engagement of DG by LASV detaches the DG complex from the adaptor utrophin
In the host cell, DG provides a molecular link between the ECM and the actin cytoskeleton
by anchorage of the cytoplasmic domain of β-DG to the cytoskeletal adapter proteins
dystrophin or utrophin. Cell entry of LASV occurs independently of the dynamics and
stability of the actin cytoskeleton (Rojek et al., 2008c). We hypothesized that virus binding,
possibly involving receptor clustering and signaling, may somehow detach DG from the
cytoskeletal adaptors, allowing subsequent actin-independent endocytosis. A major
challenge to test this hypothesis was to assess specific changes in utrophin binding to the
relatively small fraction of virus-bound DG as compared to total cellular DG. To overcome
this problem, we used recombinant retroviruses bearing the recombinant GP of LASV.
Retroviral pseudotypes containing the GP of the New World virus Amapari (AMPV), which
does not use DG as a receptor (Spiropoulou et al., 2002), served as a negative control. These
arenavirus pseudotypes, which have been previously generated and extensively
characterized in our laboratory, adopt the receptor binding characteristics and cellular
tropism of the viruses from which the GPs are derived (Rojek et al., 2007a). Importantly, the
use of retroviral pseudotypes allowed the insertion of a C-terminal FLAG-tag into LASV GP
and AMPV GP (Fig. 4A) allowing co-IP of the viral GP with associated cellular receptor
proteins. The C-terminal FLAG-tag had no adverse effect on the function of the viral GPs in
host cell attachment and entry (Rojek et al., 2008b). Retroviral pseudotypes containing
FLAG-tagged LASV GP and AMPV GP were produced and purified as described (Rojek et
al., 2008b; Rojek et al., 2007a) and detection of GP in purified pseudotypes by ELISA
revealed more efficient incorporation of LASV GP when compared to AMPV GP (Fig. 4B).
As previously shown, infection of cells with LASV pseudotypes, but not AMPV
pseudotypes or pseudotypes of VSV depended on DG (Fig. 4C), confirming their receptor
specificity.
To assess the impact of LASV GP binding on the association of cellular DG with utrophin,
we incubated LASV or AMPV pseudotypes with monolayers of WI-26 VA4 cells. A
parallel set of cells was incubated with medium only. This step was carried out in the cold to
allow receptor binding without clustering or internalization. Cells were either kept on ice or
shifted to 37 °C for 10 minutes, followed by cell lysis in the cold. Lysates prepared from
cells incubated with pseudotypes were subjected to IP with FLAG matrix. Lysates of
untreated control cells were incubated with mAb 16G4 to α-DG, combined with protein G
sepharose. Immunocomplexes and total cell lysates were probed for β-DG and utrophin in
Western blot. As shown in Fig. 5A, IP anti-FLAG in specimens incubated with LASV, but
not AMPV pseudotypes resulted in the detection of β-DG and co-IP of utrophin, suggesting
specific pull-down of LASV GP-associated DG complex. As expected, IP of α-DG resulted
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in robust co-IP of utrophin under all conditions. To quantify possible changes in the ratio of
utrophin/β-DG upon exposure of cells to LASV pseudotypes, we performed densitometric
analysis of the signals for both conditions and normalized to the utrophin/β-DG detected in
the IP of α-DG (Fig. 5B). In cells kept at 4°C, we consistently observed a significantly lower
utrophin/β-DG ratio in the LASV GP-associated receptor fraction when compared to the
DG-utrophin complexes isolated by IP with anti-α-DG antibody. This suggested that the
LASV pseudotypes associate preferentially with cellular DG that shows a weaker or more
transient association with utrophin. As shown in Fig. 5B, the temperature shift to 37 °C,
which allows clustering of the receptor and signaling to occur, resulted in a reduction of the
utrophin/β-DG ratio in LASV GP-associated DG when compared to cells kept in the cold.
This suggests that virus-induced receptor clustering and/or signaling promotes the
dissociation of the DG complex from utrophin.
To address the role of tyrosine phosphorylation in the observed virus-induced dissociation of
utrophin from DG, we tested the effect of genistein and PP2. To this end, cells were pre-
treated with genistein and PP2 for one hour, followed by exposure to LASV pseudotypes.
After removal of unbound virus, cells were shifted to 37 °C in presence of the drugs. Virus-
associated DG was isolated by IP with FLAG matrix and the ratio of utrophin/β-DG
assessed as described above. Treatment with genistein significantly reduced virus-induced
dissociation of utrophin from DG, whereas PP2 had only a weak effect (Fig. 5C, D). This
suggested that the phosphorylation of β-DG at Y892 was dispensable for the virus-induced
dissociation of utrophin from the DG complex.
To complement our inhibitor studies, we examined LASV cell entry into murine ES cells
expressing a DG variant lacking the last 15 C-terminal amino acids of β-DG (DGΔC),
including the PPxY motif containing Y892. Briefly, ES cells expressing either wild type DG
or DGΔC were infected with rLCMV-LASVGP at low multiplicity. To exclude differences
at the level of post-entry steps in LCMV replication, a recombinant LCMV expressing
VSVG was used as a control. At four hours of infection, 20 mM ammonium chloride was
added to prevent secondary infection. After 16 hours, cells were fixed and infection detected
by IF for LCMV NP. As shown in Fig. 5E, ES cells expressing DGΔC were as permissive as
wild-type cells, suggesting that the last 15 amino acids of β-DG are dispensable for LASV
cell entry.
DISCUSSION
In the present study we investigated the role of tyrosine phosphorylation for cell entry of
LASV. We show that tyrosine kinases are required for endocytosis of the virus-receptor
complex, but dispensable for virus-receptor binding. Binding of LASV to cellular
dystroglycan (DG) induced phosphorylation of DG at Y892 by src family kinases and other
tyrosine residues of β-DG by non-src kinases. Virus-induced receptor phosphorylation was
accompanied by dissociation of DG from the cytoskeletal adaptor protein utrophin, which
might facilitate virus endocytosis.
In the host cell, DG provides a molecular link between the ECM and the actin-based
cytoskeleton and has a slow turnover. However, engagement of DG by LASV results in
rapid internalization of the virus and delivery to the late endosome (Quirin et al., 2008;
Rojek et al., 2008c), suggesting marked changes in trafficking dynamics of DG induced by
virus binding. In our study, we investigated if attachment of LASV affects post-translational
modifications of DG, altering receptor trafficking in the membrane. Extending previous
studies (Kolokoltsov et al., 2012; Vela et al., 2008), we found that treatment of cells with the
broadly-specific tyrosine kinase inhibitor genistein prevented LASV cell entry at an early
step of virus internalization without affecting virus-receptor binding, providing a first link
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between tyrosine phosphorylation and viral endocytosis. Since tyrosine phosphorylation of
β-DG at Y892 by src family kinases has previously been implicated in internalization of DG
(Miller et al., 2012; Sotgia et al., 2003), we tested the effect of LASV binding on
phosphorylation of the receptor at Y892. Engagement of cellular DG by rLCMV-LASVGP
rapidly induced phosphorylation of β-DG at Y892 that was blocked by the src kinase
inhibitor PP2. The observed kinetics of Y892 phosphorylation was compatible with a role in
viral endocytosis. However, rather unexpected, treatment of cells with PP2 had no effect on
the entry kinetics of the virus. Since the cytoplasmic tail of β-DG contains four additional
putative sites of tyrosine phosphorylation, in addition to Y892, we examined virus-induced
phosphorylation at tyrosines. We found that LASV binding induced tyrosine
phosphorylation of β-DG at sites other than Y892 with similar kinetics. These tyrosine
phosphorylation events were not sensitive to PP2 and likely involved non-src tyrosine
kinases. Virus-induced tyrosine phosphorylation of β-DG was entirely abrogated by
genistein.
Using a pseudotype platform, we assessed the composition of DG complexes associated
with LASV GP upon virion attachment. We found that LASV pseudotypes associated with a
fraction of cellular DG that showed less association with utrophin. The reasons for this are
currently unclear, but may be related to different accessibility of DG as a function of its
association with utrophin and the actin cytoskeleton. In cells, DG associated with cell-
substrate adhesion structures at the lower plasma membrane tends to co-localize with
utrophin (Belkin and Smalheiser, 1996). Due to the close association with the substratum at
the basal face of the cell, DG located in such substrate-adhesion complexes may be less
accessible to the virus.
Our analysis further revealed that engagement of DG by LASV GP results in dissociation of
utrophin from β-DG. This virus-induced dissociation of utrophin could be perturbed by
genistein, but not PP2, suggesting that phosphorylation of β-DG at Y892 by src kinases was
dispensable. The efficient virus-induced dissociation of utrophin from DG in presence of
PP2 is in line with the inability of the inhibitor to perturb viral entry. However, our findings
are different from reports supporting a role for phosphorylation of β-DG at Y892 by src
kinases in the regulation of utrophin binding and endocytosis of DG in prototypic primate
cells (Sotgia et al., 2003; James et al., 2000) and myoblasts (Miller et al., 2012) in response
to endogenous substrates. The reasons for this discrepancy are currently unclear. One
possibility is that, contrary to our initial assumption, DG may not stay associated with the
virus during the entry process. In this scenario, DG would serve as an attachment factor
rather than a true entry receptor. One would have to postulate the existence of another, yet
unknown receptor molecule that would mediate viral endocytosis. The recently discovered
alternative LASV receptors Axl and Dtk (Shimojima et al., 2012) appear as interesting
candidates in this context. Alternatively binding of the multivalent virion particle to cellular
DG may induce extensive clustering and activate signaling pathways that are not triggered
by DG’s ECM ligands, allowing the virus to “bypass” a block in Y892 phosphorylation. To
address these possibilities, studies aiming at tracking the virus-DG complex in live cells are
currently launched in our laboratory.
Since virus-induced phosphorylation of β-DG is blocked by genistein, which inhibits
internalization of the virus, it is tempting to speculate that virus-induced phosphorylation of
β-DG is necessary for virus entry. However, in the host cell, DG is found associated with a
number of cellular proteins that are required for the correct assembly and stability of the DG
complex in the membrane, as well as its anchorage to the actin cytoskeleton (Barresi and
Campbell, 2006). Such “pre-formed” DG complexes represent the functional units of virus
attachment. Our data have shown that virus binding to DG results in receptor signaling.
Such virus-induced signaling may affect the composition of the virus-receptor complex by
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recruiting new proteins into the virus-DG complex and/or excluding others. During the entry
process, the “interactome” of the virus-DG complex may therefore change in a dynamic
manner resulting in sorting at the plasma membrane required for subsequent cell entry.
Candidate cellular proteins that interact with the virus-DG complex during the entry process
and are part of this “interactome” would represent potential substrates for tyrosine
phosphorylation. We cannot exclude the possibility that tyrosine phosphorylation of such
receptor-associated proteins, and not β-DG itself, is the actual target of genistein in the viral
entry process.
In sum, the data at hand suggest that attachment of LASVGP to cellular DG induces tyrosine
phosphorylation of β-DG at Y892 and other tyrosine residues accompanied by the
dissociation of DG from utrophin. The consequent detachment of virus-bound DG from the
actin-based cytoskeleton may facilitate subsequent endocytosis of the virus-receptor
complex, providing a possible link between virus-induced post-translational modification of
DG and virus entry.
EXPERIMENTAL PROCEDURES
Cell lines and viruses
WI-26 VA4 cells (ATCC CCL-95.1) were cultured in DMEM, 10 % (vol/vol) FBS,
supplemented with glutamine, and penicillin/streptomycin. Embryonic stem (ES) cells DG
(+/−), DG (−/−) have been described (Henry and Campbell, 1998). Transgenic ES cells
expressing DG lacking the last 15 amino acids (DGΔC) were generated through introduction
of a triple premature stop codon affecting all possible reading frames via targeted
homologous recombination (gift from Kevin P. Campbell).
The recombinant virus rLCMV-LASVGP has been described elsewhere (Rojek et al.,
2008c) and was produced and the titers determined as previously described (Dutko and
Oldstone, 1983). Recombinant LASV GP and AMPV GP containing a C-terminal FLAG-tag
have been described (Rojek et al., 2008b). Retroviral pseudotypes expressing GFP and
luciferase reporters were produced and concentrated, and titers determined as described
(Rojek et al., 2006). Concentrated pseudotypes were diluted in HBSS at 107 transforming
units per ml. For detection of viral GP in ELISA, purified pseudotypes were immobilized in
microtiter plates at 106 TU/ml and the viral GP detected as described (Rojek et al., 2008a).
Recombinant VSV pseudotyped with LASV GP (rVSVΔG-LASVGP), and VSV GP
(rVSVΔG-VSVG) were generated as reported previously (Kunz et al., 2005a). Virus titers
were determined by the infection of Vero E6 cell monolayers and detection of GFP-positive
cells by fluorescence microscopy.
Antibodies and reagents
Monoclonal antibodies (mAbs) 113 (anti-LCMVNP) and 83.6 (anti-LCMVGP) have been
described (Weber and Buchmeier, 1988; Buchmeier et al., 1981), as has mAb IIH6 anti-α-
DG (Ervasti and Campbell, 1991). Other mAbs included mouse IgG 8D5 anti-β-DG
(Novocastra) and mouse IgG 16C4 to α-DG (provided by Kevin P. Campbell), mouse IgG
anti-utrophin from St. Cruz Biotechnology (St. Cruz, CA), mAb cl14a to phospho-β-DG
PY982 (BD Bioscience), and mAb 4G10 to phospho-tyrosine (St. Cruz, CA). Rabbit anti-
influenza HA (Y11) was from St. Cruz Biotechnology (St. Cruz, CA). Polyclonal rabbit
anti-mouse secondary antibodies conjugated to HRP were from Dako (Glostrup, Denmark)
and goat anti-mouse antibody conjugated with Rhodamin Red X were from Jackson
Immuno Research Laboratories. Genistein and PP2 were purchased from Calbiochem. The
Bright-Glo® luciferase assay and Cell Titer Glo® assay systems were obtained from
Promega (Madison WI).
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Immunoblotting
Proteins were separated by gel electrophoresis using 12% polyacrylamide gels and
transferred to nitrocellulose. After blocking in 5% (wt/vol) skim milk in PBS, membranes
were incubated with Abs used at following concentrations: mAb 8D5, mAb cl14a, mAb
4G10, and polyclonal Abs AP83, and Y11 (10 μg/ml) in 2% (wt/vol) skim milk, PBS for 12
h at 6 °C. Secondary Abs coupled to HRP were applied 1: 5, 000 in PBS, 0.1 % (wt/vol)
Tween for 1 hour at room temperature. Blots were developed by enhanced
chemiluminescence (ECL) using Super Signal West Pico ECL Substrate or TrueBlot®
detection system (Pierce), where indicated.
Infection of cells with retroviral pseudotypes
Cells were plated in 96-well plates in a density of 104 cells/well. After 24 hours, retroviral
pseudotypes were added at the indicated MOI and incubated for 1 hour at 37°C. The viral
particles were removed, cells washed twice with DMEM, and fresh medium added. Infection
was quantified by Bright Glo® luciferase assay. Luminescence was calculated as fold-
increase over background signals obtained from uninfected cells.
Infection of cells with rLCMV-LASVGP
Cells were plated in 96-well plates in a density of 104 cells/well. After 24 hours, cells were
pre-treated with genistein or PP2 as indicated, followed by infection with rLCMV-LASVGP
at the indicated MOI for 1 hour at 37°C. Unbound virus were removed, cells washed twice
with DMEM, and fresh medium added. Infection was quantified by detection of LCMV NP
in IF as described (Kunz et al., 2004). Cell entry kinetics of rLCMV-LASV in presence and
absence of PP2 were performed as described (Rojek et al., 2008c). Blocking of infection
with mAb IIH6 was done as reported (Kunz et al., 2005b).
Virus internalization assay
Purification of rLCMV-LASVGP was performed by ultracentrifugation on a renografin
gradient. Purified LCMV was labeled with the thiol-cleavable reagent NHS-SS-biotin
(Pierce). The cleavage of the biotin label was verified by reaction with the membrane-
impermeable reducing agent Tris(2-carboxyethyl)phosphine (TCEP) (10 mM) (Pierce) for
30 min, which resulted in a loss of >95% of the biotin label. Internalization assay was
performed as described previously (Rojek et al., 2008a). Briefly, cells were cultured in 10-
cm dishes to obtain closed monolayers. Medium was removed, and cells were washed twice
with cold HBSS and chilled on ice for 5 min. Cold solution containing NHS-SS-biotinylated
rLCMVLASVGP (107 PFU/ml) in HBSS was added. After incubation for 1 h on ice,
unbound virus was removed and cells were washed with cold HBSS. For internalization,
cells were shifted to 37°C. After the indicated incubation times, medium was removed and
cells chilled on ice. TCEP (15 mM) in 50 mM HEPES, pH 7.5, 150 mM NaCl, 1 mM CaCl2,
1 mM MgCl2 was added (5 ml/dish) and applied twice for 30 min on ice. Cells were washed
three times with cold HBSS, and the remaining TCEP was quenched with 100 mM
iodoacetamide for 10 min, and cells were lysed immediately. LCMV GP2 was isolated by IP
as described (Rojek et al., 2008a). Immunocomplexes were separated by nonreducing SDS-
PAGE. Biotinylated LCMV GP2 was detected by Western blotting with HRP-conjugated
streptavidin as described above.
Detection of DG-utrophin complexes associated with LASV GP
Triplicate cultures of WI-26 VA4 cells were cultured in 10 cm plates over night to obtain
closed monolayers. Retroviral pseudotypes of LASV and AMPV (107 TU/ml in HBSS)
were added at 50 TU/cell. Parallel specimens were incubated with 10 μg/ml mAb 16C4 to α-
DG in HBSS. After incubation for one hour in the cold, cells were washed 3 times with cold
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HBSS. One series of cultures was kept on ice whereas the other was quickly shifted to 37°C
in a water bath. After 10 minutes, cells were chilled on ice. Cells were lyzed for 30 minutes
in 1% (wt/vol) β-octylglucoside, 1 mM CaCl2, 1 mM MgCl2, 150 mM NaCl, 50 mM Hepes
pH 7.5, 10% (wt/vol) glycerin supplemented with protease inhibitor cocktail Complete®
(Roche) and 1 mM PMSF. Cleared lysates were subjected to IP with FLAG matrix (Sigma)
or protein G-conjugates sepharose 4B (Sigma) for 2 hours at 6°C. After three short washes
in lysis buffer, the matrix was eluted with non-reducing SDS-PAGE sample buffer to
minimize elution of IgG from the FLAG matrix. After addition of 100 mM DTT (final
concentration) and boiling for another 5 minutes Western blot performed as described
above. For quantification, X-ray films were scanned with a Storm densitometer, and
acquired data were processed using Image Quant software.
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Fig. 1. Genistein inhibits internalization of rLCMV-LASVGP
(A) LASV infection in WI-26 VA4 cells is mediated by DG. Monolayers of WI-26 VA4
cells in M96 plates were blocked with MAb IIH6 or an unrelated mouse IgM (Control IgM)
at the indicated concentrations for 2 h at 4°C. Next, 200 PFU of rLCMV-LASVGP was
added for 45 min. Infection was assessed after 16 hours by immunofluorescence (IF)
staining for LCMV NP. Infected foci were counted in each well (means ± SD, n = 3). (B)
Cytotoxicity of genistein. WI-26 VA4 cells were treated with the indicated concentrations of
the drug for 4 hours, followed by a wash out and incubation for a total of 16 hours. Cell
viability was assessed by Cell Titer Glo® assay. Data are triplicates ± SD. (C) Inhibition of
rLCMV-LASVGP infection with genistein. WI-26 VA4 cells were treated with the indicated
concentrations of genistein for one hour, followed by infection with rLCMV-LASVGP at
multiplicity of 1, followed by wash out of the drug at 4 hours. After 12 hours of culture in
presence of 20 mM ammonium chloride, cells were fixed and infection detected by IF for
LCMV NP. Data are triplicates ± SD. (D) Inhibition of infection of VSV pseudotypes with
genistein. WI-26 VA4 cells were treated with the indicated concentrations of genistein for
one hour, followed by infection with rVSV-LASVGP and rVSV-VSVG (200 PFU/well).
After 24 hours, infection was assessed by detection of GFP positive cells in direct
fluorescence microscopy (n = 3 ± SD). (E) Schematic of the virus internalization assay (for
details, please see text). (F) Genistein treatment prevents internalization of rLCMV-
LASVGP. WI-26 VA4 cells were pre-treated with 50 μM of genistein or vehicle control
(DMSO). After one hour, cells were chilled on ice and incubated with biotin-S-S-labeled
rLCMV-LASVGP (100 particles/cell) for one hour in the cold. Unbound virus was removed,
cells shifted to 37 °C in presence or absence of genistein. After the indicated time points,
cells were chilled on ice and treated with TCEP (+TCEP) or reaction buffer only (−TCEP).
After quenching of residual TCEP, cells were lysed, viral GP isolated by IP with mAb 83.6
to GP2. Biotinylated GP2 was detected with streptavidine-HRP in Western-blot under
nonreducing conditions using enhanced chemiluminescence (ECL). The Upper blot
(+TCEP) was exposed for 10 minutes, the lower blot (−TCEP) was exposed for 1 minute.
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Fig. 2. Binding of LASV to cellular DG induces tyrosine phosphorylation of β-DG by src-family
kinases
(A) Schematic representation of C-terminally tagged DG (DGHA). The N-terminal domain
(white), the mucin-type domain (black) and the C-terminal domain (gray) of α-DG, β-DG,
and the C-terminal HA tag are indicated. (B). Detection of tyrosine phosphorylation at
residue Y892 with mAb cl14a. DGHA was transiently expressed either alone or in
combination with c-src. Parallel specimens were pretreated with 20 μM PP2 or mock treated
with vehicle (DMSO). After 48 hours, DGHA was isolated by pull-down with HA matrix.
Proteins were separated and probed in Western blot with an antibody to HA (anti-HA) or
mAb cl14a to β-DG phosphorylated at tyrosine 892 (anti-β-DG PY892). Apparent molecular
masses and the positions of β-DG are indicated. (C) Attachment of rLCMVLASVGP to cells
induces tyrosine phosphorylation of β-DG. Monolayers of WI-26 VA4 cells were incubated
with rLCMV-LASVGP or PICV (100 particles/cell) for 1 hour in the cold. Unbound virus
was removed and cells shifted to 37°C. At the indicated time points, cells were lysed and
DG enriched by WGA affinity purification. WGA-bound glycoproteins were probed in
Western-blot with mAb cl14a (anti-β-DG PY892) and antibody 8D5 to β-DG. The positions
of β-DG and β-DG PY892 are indicated. (D) Virus induced tyrosine phosphorylation of β-
DG is blocked by PP2. Monolayers of WI-26 VA4 cells were pretreated with 20 μM PP2 or
DMSO (Control) for 1 hour prior to exposure to rLCMV-LASVGP. Virus-induced
phosphorylation of β-DG at Y892 was assessed as in (C). (E) The phosphorylation of β-DG
at PY892 is not required for LASV cell entry. Monolayers of WI-26 VA4 cells were
pretreated with 20 μM PP2 or DMSO (Control) for 1 hour as in (D), followed by incubation
with rLCMV-LASVGP (MOI = 1) in the cold in presence of the drug. After 1 hour,
unbound virus was removed and pre-warmed (37 °C) medium containing the drug added. At
the indicated time points, 20 mM ammonium chloride was added and left throughout the
experiment. At 16 hours post infection, cells were fixed and infection detected by
intracellular staining for LCMV NP (means ± SD, n = 3). The apparent differences in
infection at 60 minutes were not statistically significant.
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Fig. 3. Binding of LASV to cellular DG induces tyrosine phosphorylation of β-DG by non-src
tyrosine kinases
(A) Sequence of the cytoplasic domain of human β-DG. The putative transmembrane
domain is underlined in black and tyrosine residues indicated with gray arrows. Putative
phosphorylation sites for src-family kinases are underlined and Y residues marked (arrows).
The PPxY motif including Y892 is double underlined. (B) Detection of virus-induced
tyrosine phosphorylation β-DG in presence of PP2. WI-26 VA4 cells were pretreated with
20 μM PP2 or vehicle, followed by exposure to rLCMV-LASVGP as in Fig. 2D). After the
indicated time points, β-DG was isolated by IP using mAb 8D5 against β-DG covalently
coupled to Sepharose 4B. Immunocomplexes were eluted under non-reducing conditions,
separated by SDS-PAGE and probed in Western blot using mAb cl14a to β-DGPY892 and
mAb 4G10 to tyrosine phosphate (pY). For detection of bound mouse IgG a TrueBlot®
detection system was used to avoid cross-reaction with the murine IgG heavy and light
chains. Total β-DG was detected with rabbit polyclonal antibody AP83. (C) Genistein blocks
virus-induced tyrosine phosphorylation of β-DG. Cells were pre-treated with 50 μM
genistein or vehicle (DMSO) only. After 30 minutes, rLCMV-LASVGP was added (100
particles/cell) for the indicated time points and tyrosine phosphorylation of β-DG was
assessed as in (B).
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Fig. 4. Retroviral pseudotypes
(A) Schematic representation of Flag-tagged LASV GP. The receptor-binding GP1 and
transmembrane GP2 parts are indicated. The transmembrane domain of GP2 is represented
as a grey box and the C-terminal FLAG-tag indicated. (B) Detection of GP in retroviral
pseudotypes. Retroviral pseudotypes were generated by cotransfection of packaging cell line
GP2293 expressing retroviral Gag/Pol with a GP expression plasmid and an expression
plasmid for a packable retroviral genome bearing a luciferase and a GFP reporter gene.
Pseudotypes were purified by ultracentrifugation through a sucrose cushion and re-
suspended in HBSS. Purified pseudotypes of LASV (LAS), AMPV (AMP), and VSV, as
well as pseudotypes lacking GP (C) were immobilized in microtiter plates and the viral GP
detected with mAb 83.6, combined with an HRP-conjugated secondary antibody in a colour
reaction (means ± SD, n = 3). (C) Infection of cells with LASV pseudotypes depends on
DG. DG (−/−) murine embryonic stem (ES) cells and parental DG (+/−) ES cells were
infected with pseudotypes of LASV (LAS), AMPV (AMP), and VSV, as well as
pseudotypes lacking GP (C). After 48 hours, infection was detected by luciferase assay
(means ± SD, n = 3).
Moraz et al. Page 17
Cell Microbiol. Author manuscript; available in PMC 2013 November 01.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
Fig. 5. Effect of LASV pseudotype binding on the association of DG with utrophin
Monolayers of WI-26 VA4 cells were chilled on ice and incubated with either LASV or
AMPV pseudotypes (LASV-PS, AMPV-PS) at a multiplicity of infection (MOI) of 50
transforming units (TU)/cell. Parallel specimens were incubated with mAb 16G4 to α-DG
(anti-DG). After one hour, unbound virus or mAb were removed by washing. Cells were
either kept on ice (virus binding 4°C) or shifted to 37 °C for 10 minutes (temperature shift
37°C). Cells were quickly chilled on ice, lysed and subjected to IP using FLAG matrix or
protein G-conjugated Sepharose 4B. Immunocomplexes were separated by SDS-PAGE
using 100% of the IPs anti-FLAG and 5% of the IP anti-DG. Beta-DG and utrophin were
detected on Western-blot using monoclonal antibodies 8D5 and combined with HRP-
conjugated secondary antibodies in a TrueBlot® detection system to avoid cross-reaction
with the IgG heavy chain. For the detection of total protein in cell lysates, 1/20 of the lysate
were separated by SDS-PAGE and subjected to Western-blot detection. (B) Quantification
of the signals in (A). Blots were scanned in a densitometer and the ratios of the signals for
utrophin normalized to β-DG (utrophin/β-DG) for the IPs anti-FLAG (LASV pseudotypes
only) and the IP anti-DG. For each series, the utrophin/β-DG ratio detected in the IP anti-DG
was defined as 1.0. (C) Pre-treatment with genistein, but not PP2 reduced virus-induced
dissociation of utrophin from DG. Monolayers of WI-26 VA4 cells were pre-treated with
DMSO only (control), 20 μM PP2 and 50 μM genistein for one hour. Cells were then chilled
on ice and incubated with LASV pseudotypes (LASV-PS) for one hour in the cold in
presence of drugs. Cells were then quickly shifted to 37 °C, lysed, and subjected to IP with
FLAG matrix as in (A). Precipitated β-DG and utrophin were detected in Western blot and
the ratios utrophin/β-DG determined as in (B). (D) Quantification of the data in (C). (E) The
15 C-terminal amino acids of β-DG are dispensable for LASV cell entry. Murine ES cells
expressing either wild-type DG (DG wt) or DG lacking the C-terminal 15 amino acids of β-
DG (DGΔC) were infected with rLCMV-LASVGP or rLCMV-VSVG at a multiplicity of
0.1. Infection of the cells expressing wild-type DG was set at 100% (means ± SD, n = 3).
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